US2004063614A1PendingUtilityA1

Brain-protective agent

Assignee: FUJISAWA PHARMACEUTICAL COPriority: Jul 4, 1997Filed: Oct 3, 2003Published: Apr 1, 2004
Est. expiryJul 4, 2017(expired)· nominal 20-yr term from priority
A61P 9/00C12N 2310/13C12N 15/113A61P 43/00A61K 38/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A brain-protective agent containing an NF-κB decoy. In brain diseases, the brain can be particularly effectively protected against brain disorders (for example, cerebral vasospasm following a subrachnoidal hemorrhage and apoptosis of the nerve cells following a cerebrovasucular accident or serious head injury) caused by the undesired activation of cytokines or cell adhesion factors which are regulated by NF-κB by administering the brain-protective agent containing an NF-κB decoy, i.e., a compound antadonistic specifically to a nucleic acid to which NF-κB binds.

Claims

exact text as granted — not AI-modified
1 . A brain-protective agent comprising an NF-κB decoy.  
     
     
         2 . The brain-protective agent according to  claim 1  for the brain disorder arising from encephalopathy.  
     
     
         3 . The brain-protective agent according to  claim 2  wherein the encephalopathy is a cerebrovascular accident.  
     
     
         4 . The brain-protective agent according to  claim 2  wherein the brain disorder arising from encephalopathy is cerebral vasospasm associated with subarachnoid hemorrhage.

Join the waitlist — get patent alerts

Track US2004063614A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.